Clinical Trial Update: Cardiovascular Clinical Project to Evaluate the Regenerative Capacity of CardioCell in Patients With Acute Myocardial Infarction (AMI) [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating the regenerative capacity of CardioCell in patients with acute myocardial infarction has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• CardioCell

Snippet

Sponsor: John Paul II Hospital, Krakow | Conditions: Myocardial Infarction | Phase 2, Phase 3 | Status: COMPLETED